| Angelman syndrome |
UBE3A
|
| Aristaless-relaxed homeobox gene (ARX) disorders |
ARX
|
| Autosomal dominant epilepsy with auditory features |
LG11
|
| Autosomal dominant juvenile myoclonic epilepsy |
GABRA1, CACNB4, CLCN2
|
| Autosomal dominant nocturnal frontal lobe epilepsy |
CHNRA4, CHNRNB2
|
| Benign familial neonatal convulsion |
KCNQ2, KCNQ3
|
| Benign familial neonatal-infantile seizures |
SCN2A
|
| Dravet syndrome |
SCN1A
|
| Early onset absence epilepsy |
SLC2A1
|
| Generalised epilepsy with febrile seizures plus |
SCN1A, SCN2A, SCN2B, GABRG2
|
| Hot water reflex epilepsy |
SLC1A1
|
| Juvenile myoclonic epilepsy type 1 |
EFHC1
|
| Lafora body disease |
EMP2A, NHLRC1
|
| Myoclonic epilepsy with ragged-red fibers (MERRF) |
TK, TL1, TH, TS1
|
| Neurofibromatosis |
NF1, NF2
|
| Neuronal ceroid-lipofuscinoses / Batten disease |
CLN3, CLN5, TPP1
|
| Protocadherin-19 (PCDH 19) related epilepsy |
PCDH-19
|
| Rett syndrome |
MECP2
|
| Severe myoclonic epilepsy of infancy |
SCN1A
|
| Sialidosis |
NEU1, PCDH19
|
| Tuberous sclerosis |
TSC1, TSC2
|
| Unverricht-Lundborg myoclonus epilepsy |
CTSB
|
